Key Points
Gland Pharma share price witnessed a 6.5% surge on Friday following the company's announcement that the United States Food and Drug Administration (USFDA) had successfully concluded its inspection of the Pashamylaram facility in Hyderabad..
Gland Pharma announced in a filed exchange statement that it has obtained the Establishment Inspection Report (EIR) from the US drug regulator, signifying the conclusion of the inspection process..
The USFDA conducted a pre-market inspection of the Pashamylaram facility from August 23 to 26, 2023, with the aim of evaluating the facility's adherence to the Quality System/Current Good Manufacturing Practice (CGMP) regulations for medical devices set by the USFDA..
In the July-September quarter of the fiscal year 2023-24, the company experienced a 19.56% year-on-year decline in its consolidated net profit, amounting to 194 crore, compared to 241.2 crore recorded in the same period a year earlier..
The company revealed last week that it secured provisional approval from the US Food and Drug Administration (USFDA) for the Angiotensin II Injection, 2.5 mg/mL Single Dose Vial..
You might be interested in
L&T to buy back Rs 10,000cr shares, biggest this year
26, Jul, 23India Business News: Mumbai: Larsen & Toubro, India’s largest engineering company, will buy back shares worth Rs 10,000 crore, in its second attempt to repurchase stock af.
Mankind Pharma IPO opens for subscription, GMP rises; should you subscribe to Rs 4500-crore public issue?
25, Apr, 23Mankind Pharma's IPO opened for subscription today, 25 April. Should you subscribe to India's fourth largest pharmaceutical company's IPO? Here's what experts say.
Concord Biotech Limited’s IPO to open on August, 4, sets price band at Rs 705 to Rs 741 per equity share
01, Aug, 23India Business News: Ahmedabad-based Concord Biotech Limited, a biotechnology company and one of the leading global developers and manufacturers of select fermentation-bas.
Ircon share price slumps over 8% on day 1 of OFS; government to divest up to 8% stake
07, Dec, 23Ircon share price today opened at ₹157.95 apiece on BSE. This year so far, Ircon Intl share price jumped by 179%. Ircon share price touched an intraday low of ₹157.50 and an intraday high of ₹159.90.
L&T approves Rs 10,000 crore share buyback at Rs 3,000/share
25, Jul, 23The buyback will involve 3.33 crore shares or 2.4% of the fully paid-up equity share capital. This is the first buyback announced by the company since the listing. The specific price at which the buyback will be executed may be determined by the Board soon.
HCC share price jumps over 9% to hit 52-week high on sale of Swiss arm for ₹928 crore
05, Dec, 23HCC share price touches a 52-week high after the company's arm enters into a share purchase agreement with Demathieu Bard for divestment worth ₹928 crore.
ACC share price gains as Q1 results beat estimates; brokerages raise targets
28, Jul, 23The Adani group cement manufacturing company ACC Ltd posted a net profit of ₹466.14 crore for the quarter ending June 2023, registering a growth of 105% as compared to ₹227.35 crore in the corresponding period of last year.
Titan share price hits record high. Rekha Jhunjhunwala's net worth jumps ₹2400 crore in two months
30, May, 23Rekha Jhunjhunwala's portfolio: Titan share price has seen 65% increase in last two months, hitting a lifetime high of ₹2,841.90 per share today
US regulators inspect Dr Reddy's, other Indian pharma majors
05, Dec, 23The U.S. Food and Drug Administration is inspecting Dr Reddy's (REDY.NS) research and development centre in the southern Indian city of Hyderabad, the pharma company said on Tuesday.
Zee Entertainment posts a mixed Q2 performance; what's in it for investors?
10, Nov, 23Throughout the week, Zee Ent share price has been under pressure and lost about 6%. According to Ruchit Jain, Lead Research Analyst at 5paisa, Zee Ent stock is consolidating in a broad range of 240-275.